New research finds that measuring blood levels of the medication hydroxychloroquine (Plaquenil) in people with lupus may be an effective way to predict risk of retinopathy, a disease which results in impaired or complete loss of vision.
Research Supports Measuring Blood for Hydroxychloroquine Levels
Hydroxychloroquine (Plaquenil®) is the most prescribed medication in the treatment of lupus and has numerous benefits including prevention of flares, prolonged survival, and other positive outcomes. Medication non-adherence is reported in up to 80% of people with lupus and is associated with reduced health outcomes.
